Offer - Urjas Oil for just ₹ 1 X
Metolactone 2.5 Mg/50 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Metolactone 2.5 Mg/50 Mg Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Metolactone 2.5 Mg/50 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Metolactone 2.5 Mg/50 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Metolactone 2.5 Mg/50 Mg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Metolactone 2.5 Mg/50 Mg Tablet's effect is Severe during pregnancy and Mild for lactating mothers. In addition, Metolactone 2.5 Mg/50 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Metolactone 2.5 Mg/50 Mg Tablet related warnings section.
Metolactone 2.5 Mg/50 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Liver Disease, Diabetes are examples of such conditions. Other contraindications of Metolactone 2.5 Mg/50 Mg Tablet have been discussed in the sections ahead.
Besides this, Metolactone 2.5 Mg/50 Mg Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Metolactone 2.5 Mg/50 Mg Tablet is not safe while driving, and is not addiction.
Metolactone 2.5 Mg/50 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Metolactone 2.5 Mg/50 Mg Tablet safe for pregnant women?
Metolactone has many dangerous side effects in pregnant women. If you are pregnant, do not consume Metolactone without medical advice.
Is the use of Metolactone 2.5 Mg/50 Mg Tablet safe during breastfeeding?
Metolactone has been seen to have minimal side effects on breastfeeding women.
What is the effect of Metolactone 2.5 Mg/50 Mg Tablet on the Kidneys?
Metolactone may have mild side effects on the kidneys.
What is the effect of Metolactone 2.5 Mg/50 Mg Tablet on the Liver?
In the absence of any scientific study on the side effects of Metolactone on the liver, information on safety of Metolactone for liver is unavailable.
What is the effect of Metolactone 2.5 Mg/50 Mg Tablet on the Heart?
Metolactone is rarely harmful for the heart.
Metolactone 2.5 Mg/50 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metolactone 2.5 Mg/50 Mg Tablet unless your doctor advises you to do so -
Is this Metolactone 2.5 Mg/50 Mg Tablet habit forming or addictive?
No, there is no any evidence that Metolactone 2.5 Mg/50 Mg Tablet is addictive.
Interaction between Food and Metolactone 2.5 Mg/50 Mg Tablet
Taking Metolactone 2.5 Mg/50 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Metolactone 2.5 Mg/50 Mg Tablet
Consult your doctor before consuming alcohol while taking Metolactone 2.5 Mg/50 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 846
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zaroxolyn® (metolazone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Microx® (metolazone)